Unknown

Dataset Information

0

Crystal Structure of a Tetrameric Type II ?-Carbonic Anhydrase from the Pathogenic Bacterium Burkholderia pseudomallei.


ABSTRACT: Carbonic anhydrase (CA) is a zinc enzyme that catalyzes the reversible conversion of carbon dioxide to bicarbonate and proton. Currently, CA inhibitors are widely used as antiglaucoma, anticancer, and anti-obesity drugs and for the treatment of neurological disorders. Recently, the potential use of CA inhibitors to fight infections caused by protozoa, fungi, and bacteria has emerged as a new research line. In this article, the X-ray crystal structure of ?-CA from Burkholderia pseudomallei was reported. The X-ray crystal structure of this new enzyme was solved at 2.7 Å resolution, revealing a tetrameric type II ?-CA with a "closed" active site in which the zinc is tetrahedrally coordinated to Cys46, Asp48, His102, and Cys105. B. pseudomallei is known to encode at least two CAs, a ?-CA, and a ?-CA. These proteins, playing a pivotal role in its life cycle and pathogenicity, offer a novel therapeutic opportunity to obtain antibiotics with a different mechanism of action. Furthermore, the new structure can provide a clear view of the ?-CA mechanism of action and the possibility to find selective inhibitors for this class of CAs.

SUBMITTER: Angeli A 

PROVIDER: S-EPMC7287614 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Crystal Structure of a Tetrameric Type II β-Carbonic Anhydrase from the Pathogenic Bacterium <i>Burkholderia pseudomallei</i>.

Angeli Andrea A   Ferraroni Marta M   Pinteala Mariana M   Maier Stelian S SS   Simionescu Bogdan C BC   Carta Fabrizio F   Del Prete Sonia S   Capasso Clemente C   Supuran Claudiu T CT  

Molecules (Basel, Switzerland) 20200512 10


Carbonic anhydrase (CA) is a zinc enzyme that catalyzes the reversible conversion of carbon dioxide to bicarbonate and proton. Currently, CA inhibitors are widely used as antiglaucoma, anticancer, and anti-obesity drugs and for the treatment of neurological disorders. Recently, the potential use of CA inhibitors to fight infections caused by protozoa, fungi, and bacteria has emerged as a new research line. In this article, the X-ray crystal structure of β-CA from <i>Burkholderia pseudomallei</i>  ...[more]

Similar Datasets

| S-EPMC7191908 | biostudies-literature
| S-EPMC6203986 | biostudies-literature
| S-EPMC2937836 | biostudies-literature
| S-EPMC4908529 | biostudies-literature
| S-EPMC7247680 | biostudies-literature
| S-EPMC2865367 | biostudies-literature
| S-EPMC7528686 | biostudies-literature
| S-EPMC7226357 | biostudies-literature
| S-EPMC9969396 | biostudies-literature
| S-EPMC4505086 | biostudies-literature